Experiment of Diaphragmatic Stasis Expelling Decoction Reversing MDR-1 Expression in Transplantation Tumor in Nude Mice
-
摘要: 目的 探讨膈下逐瘀汤对HCT-8/5-Fu裸鼠移植瘤多药耐药基因MDR-1表达的影响。方法 MTT 法确认人结肠腺癌细胞HCT-8/5-Fu的耐药性及对其他化疗药VCR、VP-16、DDP的交叉耐药性后，将耐药细胞HCT-8/5-Fu接种于BABL/c无胸腺裸鼠右腋下，建立耐药性稳定的裸鼠移植瘤模型。移植瘤裸鼠模型随机分为四组：空白对照组(对照组)、5-Fu组、膈下逐瘀汤组(DSED组)、膈下逐瘀汤+5-Fu组(DSED+5-Fu组)。其中对照组予0.9%氯化钠溶液灌胃给药，其余组予腹腔注射5-Fu和(或)中药灌胃。连续给药14 天后颈椎脱臼处死裸鼠。观察各组裸鼠移植瘤生长情况；RT-PCR法检测各瘤组织MDR-1 mRNA表达。结果 膈下逐瘀汤+5-Fu组、膈下逐瘀汤组、5-Fu组对裸鼠移植瘤的抑瘤率分别为54.9%、32.4%和7.0%（P<0.01）。RT-PCR结果显示膈下逐瘀汤+5-Fu组及膈下逐瘀汤组MDR-1 mRNA的表达量与对照组相比明显下降（P<0.01），5-Fu组与对照组相比MDR-1 mRNA表达量略有升高，但差异无统计学意义。结论 膈下逐瘀汤对大肠癌多药耐药裸鼠移植瘤生长具有抑制作用，其机制可能与膈下逐瘀汤通过逆转耐药移植瘤多药耐药基因表达，增强肿瘤细胞对药物的敏感度。
-
关键词:
- 裸鼠 /
- HCT-8/5-Fu /
- MDR-1 /
- 膈下逐瘀汤
Abstract: Objective To investigate the effects of diaphragmatic stasis expelling decoction on the multidrug resistance gene expression in transplantable tumor cells in nude mice bearing cell line HCT-8/5-Fu. Methods MTT was applied to confirm the drug resistance of human colonic carcinoma cell line HCT-8/5-Fu and the cross resistance towards other chemotherapy drugs, such as VCR, VP-16 and DDP. The model of transplantable tumor in nude mice with stable drug resistance was established by planting resistant cell line HCT-8/5-Fu into the right armpit of BABL/c nude mice without thymus. A total of 28 nude mice were randomly divided into four groups: control group, diaphragmatic stasis expelling decoction group(DSED group), 5-Fu group and diaphragmatic stasis expelling decoction plus 5-Fu group(DSED+5-Fu group). The control group received an intragastric administration of 0.9% sodium chloride solution and others received an intraperitoneal injection of 5-Fu or an intragastric administration of traditional Chinese medicine. Drug delivery was lasted for 14 days before the mice were executed. The growth of transplantable tumors in nude mice in all groups was observed. MDR-1 expression in all tumor tissues was detected by RT-PCR. Results Tumor inhibition rates of DSED+5-Fu group, DSED group and 5-Fu group were 54.9%, 32.4%, and 7.0% respectively(P<0.01). RT-PCR results showed that the expression amounts of MDR-1 mRNA in DSED+5-Fu group and DSED group were obviously less than that in control group (P<0.01). The expression amount of MDR-1 mRNA in 5-Fu group was increased slightly compared with the control group with no statistical significance. Conclusion Diaphragmatic stasis expelling decoction has inhibitory effect on the growth of transplantable tumor in nude mice with multi-drug resistance to colon carcinoma. The mechanism may be related to diaphragmatic stasis expelling decoction reversing MDR-1 mRNA expression of transplantable tumor in nude mice, therefore to enhance the sensitivity to drugs of tumor cells.-
Key words:
- Nude mice /
- HCT-8/5-Fu /
- MDR-1 /
- Diaphragmatic stasis expelling decoction(DSED)
-
-
[1] Wang JH, Li SR. Retrospective analysis of colorectal cancer screening and early diagnosis in China:1994-2005[J].Wei Chang Bing Xue, 2006, 11(4): 245-50.[王继恒, 李世荣. 我国结直肠癌 筛查和早期诊断十年回顾: 1994-2005[J].胃肠病学, 2006, 11(4): 24 5-50.] [2] Urruticoechea A, Alemany R, Balart J, et al. Recent advances in cancer therapy: an overview[J].Curr Pharm Des, 2010, 16(1):3-10. [3] Huang YR,Zhou H,Fei XY, et al. Influence of GXZY decoction on expression and regulation of cancer gene bax,bcl-2,P53of human hepatocarcinom cell[J].Zhong Xi Yi Jie He Gan Bing Za Zhi,2008, 18(6): 355-6,366.[黄廷荣, 周虹, 费新应, 等.膈下逐瘀 汤加减对人肝癌细胞bax、bcl-2、P53基因表达调控的影响[J]. 中西医结合肝病杂志, 2008, 18(6): 355-6, 366.] [4] Lian YY, Zhao JR, Ren R, et al.Experimental study of decoction for removing blood stasis in diaphragm combined with cyclophosphamide on inducing apoptosis of Hca-f liver cancer mice[J]. Shan Xi Zhong Yi,2010,26(3):50-1,56. [连媛媛, 赵金茹, 任蕊, 等. 膈下逐瘀汤联合环磷酰胺诱导Hca-f肝癌小鼠细胞调 亡的实验研究 [J]. 山西中医, 2010, 26(3): 50-1, 56.] [5] Zhang BN. Infradiaphragmatic Stasis-Expelling Decoction for survival quality of advanced pancreatic cancer [J].Liaoning Zhong Yi Za Zhi 2008, 35(10): 1518-9. [张宝南. 膈下逐瘀汤对晚期胰 腺癌生存质量的影响[J]. 辽宁中医杂志, 2008, 35(10): 1518-9.] [6] Kim IJ, Bae YT, Kim SJ, et al. Determination and predicition of P-glycoprotein and mulidrug-resisitance-related protein expression in breast cancer with double-phase technetium- 99 m sestamibi scintimammography. Visual and quantitative analyses[J]. Oncology, 2006, 70(6): 403-10. [7] Liao SL, Wang P. Research progress on multidrug resistance mechanism of cancer cells and its reversal agents[J].Guo Wai Yi Yao Kang Sheng Su Feng Ce, 2008, 29(1):7-11. [廖绍兰, 王平. 肿瘤多药耐药机制就逆转剂的研究进展[J]. 国外医药抗生素分 册, 2008, 29(1): 7-11.] [8] Sun HJ, Wang XQ, Yu LM, et al. The study of Paeonol for MDR’ s reverse action[J].Jie Pou Ke Xue Jin Zhan, 2000, 6(1):59-62.[孙 慧君, 王晓琦, 于丽敏, 等. 丹皮酚对MDR逆转作用的研究[J]. 解剖科学进展, 2000, 6(1): 59-62.] [9] Lu WD, Fu ZX, Tan Y, et al. Curcumin reverses multidrug resistance in HCT-8/VCR nude mice xenograft[J].Di San Jun Yi Da Xue Xue Bao,2011,33(4):376-80. [卢伟东, 傅仲学, 覃勇, 等. 姜黄 素逆转结肠癌裸鼠移植瘤多药耐药研究[J]. 第三军医大学学报, 20 11, 33(4): 376- 80.] [10] Shi YQ, Tian TD.Experiment of Panax Notoginseng Saponins reversing multi-resistance of K56/VCR cells in vitro[J]. Zhongguo Zhong Yi Yao Ke Ji, 2005, 12(5):292-4.[史亦谦,田同德.三七总 皂甙体外逆转K56/VCR细胞多药耐药的实验研究[J]. 中国中 医药科技, 2005, 12(5): 292-4.] [11] Zhao ZY. Influence of Llexonin on the cytotoxic effect of daunorubicin on leukemia cells[J]. Hu,nan Zhong Yi Za Zhi, 2003, 19 (5):53.[赵早云.毛冬青甲素影响柔红霉素对白血病细胞的细 胞毒作用研究[J]. 湖南中医杂志, 2003, 19(5): 53.] [12] Takara K, Sakaeda T, Okumura K.An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy[J]. Curr Pharm Des, 2006, 12(3): 273-86.
计量
- 文章访问数: 1118
- HTML全文浏览量: 367
- PDF下载量: 436
下载:
